Introduction
============

Infection is a major challenge in the intensive care unit (ICU). Cited prevalence rates of ICU infection vary between 45% to 58% \[[@B1],[@B2]\], and incidence rates between 30% to 35% \[[@B3],[@B4]\]. Infections are already present on admission to the ICU in about 50% of cases; rates are perhaps even higher in studies limited to critically ill patients \[[@B1]-[@B6]\].

It has been shown that infections originating from the urinary tract usually have a better outcome than infections from other sources \[[@B7]-[@B10]\]. However, whether there are differences in outcomes for other sources of sepsis is not well defined. Lung and abdominal infections are the most common infections in the ICU \[[@B3],[@B4],[@B6],[@B11]\], and several studies have suggested that, although respiratory infections are more common, abdominal infections may be more severe \[[@B3],[@B10],[@B12]-[@B15]\]. However, whether this translates into worse outcomes is unclear. Importantly, if outcomes vary according to the source of infection, this may impact on clinical trial design, as currently patients with infections from different sources are often grouped together.

The aim of the present study was, therefore, to investigate whether the presence at ICU admission of infections originating in these two sites, abdomen and lung, had any impact on patterns of organ failure or on patient outcome. For this purpose, we used the database of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study \[[@B6]\], a large systematic cohort study performed in European ICU patients.

Materials and methods
=====================

Study design
------------

The SOAP study was a prospective multicenter observational study designed to evaluate the epidemiology and characteristics of sepsis in European countries and was initiated by a working group of the European Society of Intensive Care Medicine. Full details of recruitment, data collection and management have been provided elsewhere \[[@B6]\]. Briefly, all adult patients (\> 15 years old) admitted to a participating center (see Additional file [1](#S1){ref-type="supplementary-material"} for a list of participating countries and centers) between 1 and 15 May 2002 were included, except patients who stayed in the ICU for less than 24 hours for routine postoperative surveillance. Due to the observational character of the study which did not require any deviation from routine medical care, institutional review board approval was either waived or expedited in participating institutions and informed consent was not required. Patients were followed up until death, hospital discharge, or for 60 days.

Data collection and management
------------------------------

Data were collected prospectively using pre-printed case report forms and entered centrally by medical personnel. Data collection on ICU admission included demographic data, comorbid diseases, admission category, source of admission and admission diagnosis. Clinical and laboratory data needed to calculate the Simplified Acute Physiology Score II (SAPS II) were reported as the worst value within 24 hours after hospital admission \[[@B16]\]. Evaluation of organ function was made using the Sequential Organ Failure Assessment (SOFA) score, based on the most abnormal value for each of the six organ systems \[[@B17]\]. Daily collection of data included infection characteristics, organ function and the need for special supportive modalities such as mechanical ventilation, hemofiltration and hemodialysis.

Definitions
-----------

Infection was defined as the presence of a pathogenic microorganism in a sterile milieu and/or clinically suspected infection, plus the administration of antibiotics. Clinically suspected infection was diagnosed at the discretion of the attending physician. Sepsis and severe sepsis and septic shock were defined by standard criteria \[[@B18]\]. Organ failure was defined as a Sequential Organ Failure Assessment (SOFA) score \> 2 for the organ in question \[[@B17]\]. Early organ failure and late organ failure were defined as those occurring within and after 48 hours of a diagnosis of sepsis, respectively. For the purposes of this substudy, two groups were identified: Patients with abdominal infection (microbiologically proven or clinical diagnosis) on admission to the ICU without any concurrent respiratory infection and those with respiratory infections (microbiologically proven or clinical diagnosis) on ICU admission without concurrent abdominal infection. Secondary infections were defined as infections occurring more than 24 hours after onset of a preexisting infection, at a site other than the abdominal or respiratory system for patients in the abdominal or respiratory groups, respectively.

Statistical analysis
--------------------

Data were analyzed using the Statistical Package for Social Sciences (SPSS) for Windows, version 17.0 (SPSS Inc., Chicago, IL, USA). A Kolmogorov-Smirnov test was used, and histograms and normal-quantile plots were examined to verify the normality of distribution of continuous variables. Discrete variables are expressed as counts (percentage) and continuous variables as means ± SD or median (25^th^to 75^th^percentiles). For demographic and clinical characteristics of the study groups, differences between groups were assessed using a chi-square, Fisher\'s exact test, Student\'s t-test or Mann-Whitney U test, as appropriate. We performed a multivariate logistic regression analysis with development of secondary infection as the dependent factor to investigate the influence of length of ICU stay on the development of secondary infection in abdominal and respiratory groups. Variables considered for the analysis included, demographic data, co-morbidities, SAPS II score on admission, type of microorganism, organ failure assessed by the SOFA score. Only variables associated with a higher risk of development of secondary infection (*P*\< 0.2) on a univariate basis were modeled. All variables included in the model were tested for colinearity. Interaction terms involving combinations between length of ICU stay and presence in the abdominal or respiratory group were tested. A Hosmer and Lemeshow goodness of fit test was performed and odds ratios and their corresponding 95% confidence intervals were calculated \[[@B19]\]. We also performed a multivariate Cox proportional hazard model with time to in-hospital death as the dependent factor. Variables included in the Cox regression analysis were: age, gender, comorbid diseases, SAPS II and SOFA scores on admission, the type of admission (medical or surgical), source of admission, admission diagnosis, the presence of sepsis, early organ failure, and the need for mechanical ventilation or renal replacement therapy during the ICU stay. Variables were introduced in the model if significantly associated with a higher risk of in-hospital death on a univariate basis at a *P*-value \< 0.2. Colinearity between variables was excluded prior to modeling. The time dependent covariate method was used to check the proportional hazard assumption of the model; an extended Cox model was constructed, adding interaction terms that involve time, that is, time dependent variables, computed as the by-product of time and individual covariates in the model (time × covariate). Individual time-dependent covariates were introduced one by one and in combinations in the extended model, none of which was found to be significant. A stepwise approach was used and presence in the abdominal or respiratory group variable was forced as the last step in the model. A Kaplan-Meier survival analysis was performed and survival between groups was compared using a Log rank Test. All statistics were two-tailed and a *P*\< 0.05 was considered to be statistically significant.

Results
=======

Study population
----------------

Of the 3,147 patients enrolled in the SOAP study, 777 (25%) had sepsis on admission to the ICU; of these, 162 (21%) had abdominal infection without concurrent respiratory infection and 380 (49%) had respiratory infection without concurrent abdominal infection. The baseline characteristics of the patients are summarized in Table [1](#T1){ref-type="table"}. Age, sex, SAPS II and SOFA scores were similar in the two groups. Patients with abdominal infections were more likely to be surgical admissions and to have been referred from the operating room or recovery room; they were more likely than patients with respiratory infections to have cancer but less likely to have chronic obstructive pulmonary disease (COPD) or hematologic cancer. Patients with respiratory infection were admitted mainly because of respiratory (57%), cardiovascular (19%) and neurologic diagnoses (13%), while patients with abdominal infection were primarily admitted because of digestive/liver (40%) and cardiovascular diagnoses (34%).

###### 

Baseline characteristics and outcomes

  ------------------------------------------------------------------------------------------------------------
  Characteristic                   All patients\   Abdominal infection\   Respiratory infection\   *P*-value
                                   (n = 542)       (n = 162)              (n = 380)                
  -------------------------------- --------------- ---------------------- ------------------------ -----------
  Age, years                       63.2 ± 15.7     65.1 ± 15.0            62.4 ± 16.0              0.11

  Male                             314 (58.4%)     89 (55.3%)             225 (59.7%)              0.34

  SAPS II score                    43.6 ± 17.1     43.1 ± 17.7            43.9 ± 16.8              0.42

  SOFA score                       6.5 ± 4.1       6.4 ± 4.0              6.6 ± 4.2                0.65

  Co-morbidities                                                                                   

   Cancer                          79 (14.6%)      34 (21.0%)             45 (11.8%)               0.006

   Hematologic cancer              26 (4.8%)       2 (1.2%)               24 (6.3%)                0.01

   COPD                            107 (19.7%)     19 (11.7%)             88 (23.2%)               0.002

   Cirrhosis                       26 (4.8%)       10 (6.2%)              16 (4.2%)                0.32

   HIV and/or AIDS                 7 (1.3%)        0                      7 (1.8%)                 0.10

   Heart failure                   42 (7.7%)       8 (4.9%)               34 (8.9%)                0.11

   Diabetes                        35 (6.5%)       9 (5.6%)               26 (6.8%)                0.57

  Admission category                                                                               

   Medical                         333 (61.4%)     32 (19.8%)             301 (79.2%)              \< 0.001

   Surgical                        209 (38.6%)     130 (80.2%)            79 (20.8%)               \< 0.001

    Elective                       82 (15.1%)      35 (21.6%)             47 (12.4%)               

    Emergency                      127 (23.4%)     95 (58.6%)             32 (8.4%)                

  Source of admission                                                                              \< 0.001

   ER/Ambulance                    118 (24.0%)     17 (11.6%)             101 (29.3%)              

   Hospital floor                  191 (38.9%)     40 (27.4%)             151 (43.8%)              

   OR/Recovery                     126 (25.7%)     82 (56.2%)             44 (12.8%)               

   Hospital other                  56 (11.4%)      7 (4.8%)               49 (14.2%)               

  Admission diagnosis                                                                              \< 0.001

   Monitoring                      15 (2.8%)       7 (4.5%)               8 (2.1%)                 

   Neurologic                      51 (9.5%)       3 (1.9%)               48 (12.7%)               

   Respiratory                     229 (42.8%)     15 (9.6%)              214 (56.6%)              

   Cardiovascular                  123 (23.0%)     53 (33.8%)             70 (18.5%)               

   Renal                           14 (2.6%)       9 (5.7%)               5 (1.3%)                 

   Digestive/liver                 73 (13.6%)      63 (40.1%)             10 (2.6%)                

   Trauma                          16 (3.0%)       4 (2.5%)               12 (3.2%)                

   Others                          14 (2.7%)       3 (2.0%)               11 (2.9%)                

  Sepsis syndromes                                                                                 

   Severe sepsis                   391 (72.1%)     113 (69.8%)            278 (73.2%)              0.41

   Septic shock                    177 (32.7%)     65 (40.1%)             112 (29.5%)              0.01

  Length of ICU stay (days)        6 (3 - 13)      6 (2 - 15)             6 (3 - 13)               0.95

  Length of hospital stay (days)   21 (10 - 44)    27 (13 - 48)           20 (10 - 41)             0.02

  ICU mortality                    157 (29.0%)     47 (29.0%)             110 (28.9%)              0.98

  Hospital mortality               204 (37.6%)     60 (37.5%)             144 (38.1%)              0.89
  ------------------------------------------------------------------------------------------------------------

Data are expressed as mean ± standard deviation, number (percentage), or median (interquartile range). AIDS: acquired immune deficiency syndrome; COPD: chronic obstructive pulmonary disease; ER: emergency room; HIV: human immunodeficiency virus; ICU: intensive care unit; OR: operating room; SAPS II: Simplified Acute Physiology Score; SOFA: Sequential Organ Failure Assessment

Infection-related characteristics
---------------------------------

Table [2](#T2){ref-type="table"} shows the major microbiological data. Microbiologic cultures were positive in 46% of the patients. Diagnostic criteria for infection and the overall rates of Gram-positive, Gram-negative, or fungal infection were similar in the two groups. The most commonly isolated organisms in patients with abdominal infections were *Staphylococcus aureus*and *Streptococcus*group D, and in patients with respiratory infections, the most commonly isolated organisms were *S. aureus*and *Pseudomonas*species. *Streptococcus pneumoniae*infections were more common in patients with respiratory than in those with abdominal infections (4.7% vs. 0.6%, *P*= 0.02), while *Streptococcus*group D (18.5% vs. 6.3%, *P*\< 0.001) and any streptococcal (24.1% vs. 12.9%, *P*\< 0.001) infections were more common in patients with abdominal infections. *Escherichia coli*(15.4% vs. 7.6%, *P*= 0.006) and *Candida*non-albicans (6.2% vs. 2.4%, *P*= 0.027) infections were also more common in patients with abdominal infections than in those with respiratory infections.

###### 

Diagnostic criteria for infection and the microorganisms isolated in patients with abdominal and respiratory infections

  ----------------------------------------------------------------------------------------------------------
  Characteristic                 All patients\   Abdominal infection\   Respiratory infection\   *P*-value
                                 (n = 542)       (n = 162)              (n = 380)                
  ------------------------------ --------------- ---------------------- ------------------------ -----------
  Diagnostic criteria                                                                            

   Isolates only                 44 (8.1%)       9 (5.6%)               35 (9.2%)                0.17

   Clinical only                 294 (54.2%)     91 (56.2%)             203 (53.4%)              0.57

   Both                          204 (37.6%)     62 (38.3%)             142 (37.4%)              0.85

  Class/microorganism                                                                            

   Gram-positive                 130 (23.9%)     42 (25.9%)             88 (23.2%)               0.58

   Gram-negative                 144 (26.5%)     43 (26.5%)             101 (26.6%)              0.64

   Anaerobes                     9 (1.6%)        7 (4.3%)               2 (0.5%)                 0.45

   Atypical microorganisms       4 (0.7%)        0                      4 (1.1%)                 0.323

   Fungi                         81 (14.9%)      30 (18.5%)             51 (13.4%)               0.148

  Gram-positive                                                                                  

   Any *Staphylococcus*          119 (22.0%)     36 (22.2%)             83 (21.8%)               0.92

    *Staphylococcus aureus*      91 (16.8%)      30 (18.5%)             61 (16.1%)               0.48

     MRSA                        59 (10.9%)      22 (13.6%)             37 (9.7%)                0.18

    *Staphylococcus*, others     70 (12.9%)      19 (11.7%)             51 (13.4%)               0.59

   Any *Streptococcus*           88 (16.2%)      39 (24.1%)             49 (12.9%)               \< 0.001

    *Streptococcus*group D       54 (10.0%)      30 (18.5%)             24 (6.3%)                \< 0.001

    *Streptococcus pneumoniae*   19 (3.5%)       1 (0.6%)               18 (4.7%)                0.02

    *Streptococcus*, others      19 (3.5%)       9 (5.6%)               10 (2.6%)                0.09

   Gram-positive bacilli         15 (2.8%)       3 (1.9%)               12 (3.2%)                0.57

   Gram-positive, others         10 (1.8%)       1 (0.6%)               9 (2.4%)                 0.29

  Gram-negative                                                                                  

   *Pseudomonas*species          67 (12.4%)      19 (11.7%)             48 (12.6%)               0.77

   *Escherichia coli*            54 (10.0%)      25 (15.4%)             29 (7.6%)                0.006

   *Enterobacter*                25 (4.6%)       11 (6.8%)              14 (3.7%)                0.11

   *Klebsiella*                  25 (4.6%)       6 (3.7%)               19 (5.0%)                0.51

   *Proteus*                     15 (2.8%)       6 (3.7%)               9 (2.4%)                 0.38

   *Acinetobacter*               17 (3.1%)       2 (1.2%)               15 (3.9%)                0.11

   *Haemophilus*                 12 (2.2%)       1 (0.6%)               11 (2.9%)                0.12

   Gram-negative bacilli         36 (6.6%)       12 (7.4%)              24 (6.3%)                0.64

   Gram-negative, others         90 (16.6%)      26 (16.0%)             64 (16.8)                0.82

  Fungi                                                                                          

   *Candida albicans*            61 (11.3%)      21 (13.0%)             40 (10.5%)               0.41

   *Candida*, others             19 (3.5%)       10 (6.2%)              9 (2.4%)                 0.02

   Fungi, others                 7 (1.3%)        2 (1.2%)               5 (1.3%)                 1

  Viral/parasitic                9 (1.7%)        1 (0.6%)               8 (2.1%)                 0.21
  ----------------------------------------------------------------------------------------------------------

CSF: cerebrospinal fluid; MRSA: methicillin-resistant *S. aureus*; *Staphylococcus*, others includes methicillin-sensitive *S. aureus*and *Staphylococcus*coagulase negative methicillin-sensitive; *Streptococcus*, others includes *Streptococcus*A, B, C, G group and others; Gram-positive bacilli includes, *Moraxella*and others; Gram-negative, others includes *Salmonella, Serratia, Citrobacter, Stenotrophomonas maltophilia, Campylobacter*, other enterobacteroids, Gram-negative cocci; Anaerobes includes *Clostridium, Bacteroides*, anaerobic cocci, and others; Atypical microorganisms includes *Mycobacteria, Chlamydia, Rickettsia, Legionella pneumonia;*Fungi, others includes *Aspergillus*and others. The microorganism was considered once per patient even if present in more than one site.

Secondary infections were more common in patients with abdominal infections (70 patients, 43%), than in those with respiratory infections (119 patients, 31%), *P*= 0.010. Thirty-five patients (22%) with abdominal infections developed respiratory infections later during the ICU stay and 15 patients (4%) with respiratory infections developed abdominal infections (Table [3](#T3){ref-type="table"}). Patients with abdominal infection on admission were more likely to develop secondary skin/wound infection (16% vs. 5.5%, *P*\< 0.001) whereas patients with respiratory infections were more likely to develop secondary urinary infections (9.2% vs. 1.9%, *P*\< 0.001). Patients in the abdominal group who developed secondary infections had a longer ICU stay than those who did not (12 (5.7 to 27.3) days versus 9.8 (4.6 to 21.9), *P*\< 0.05). Multiple logistic regression analysis showed that the relationship between the abdominal group and the development of secondary infection was related to ICU stay (interaction parameter = 0.069, *P*= 0.011 (Table [4](#T4){ref-type="table"}). Specifically, the odds ratio of developing secondary infections increased with increasing duration of ICU stay in the abdominal group (Figure [1](#F1){ref-type="fig"}).

###### 

Type of secondary infections

  ----------------------------------------------------------------------
                Abdominal infection   Respiratory infection   *P-*\
                                                              value
  ------------- --------------------- ----------------------- ----------
  Respiratory   35 (21.6%)            NA                      \-

  Abdominal     NA                    15 (3.9%)               \-

  Skin/wound    26 (16.0%)            21 (5.5%)               \< 0.001

  Other         15 (9.3%)             27 (7.1%)               0.39

  Unknown       4 (2.5%)              5 (1.3%)                0.46

  Bloodstream   28 (17.3%)            48 (12.6%)              0.15

  Urinary       3 (1.9%)              35 (9.2%)               \< 0.001

  Catheter      14 (8.6%)             20 (5.3%)               0.14

  CSF           0                     2 (0.5%)                1
  ----------------------------------------------------------------------

NA: not applicable

###### 

Multiple logistic regression analysis in patients with abdominal infections. The development of secondary infection was the dependent variable

                                               Estimated coefficient   SD      Odds ratio (95% CI)      *P*-value
  -------------------------------------------- ----------------------- ------- ------------------------ -----------
  SAPS II score, per point                     0.016                   0.006   1.016 (1.005 to 1.028)   0.005
  ICU length of stay, per day                  0.055                   0.011   1.057 (1.034 to 1.079)   \< 0.001
  Abdominal/respiratory variable                                                                        
   Respiratory infection                       Reference                                                
   Abdominal infection                         -0.076                  0.316   0.927 (0.499 to 1.721)   0.810
  Abdominal/respiratory infection by ICU LOS   0.069                   0.027   1.071 (1.016 to 1.129)   0.011

CI: confidence interval; SD: standard error of the estimate; Hosmer and Lemeshow Chi square 7.636, *P*= 0.470. The percentage of correct classifications is 71.4.

![**The odds ratios of developing secondary infection in the abdominal group for different durations of ICU stay**. The solid line represents the point of significance; ICU stays longer than seven days were associated with a significant risk of developing secondary infection.](cc8909-1){#F1}

Morbidity and mortality
-----------------------

Although the incidence of severe sepsis on admission was similar in the two groups (around 70%), more patients with abdominal infection had septic shock on admission than patients with respiratory infection (40.1% vs. 29.5%, *P*= 0.016). However, when considering the incidence of sepsis syndromes during the whole ICU stay, these differences lost statistical significance (Table [5](#T5){ref-type="table"}).

###### 

Organ dysfunction patterns

  ------------------------------------------------------------------------------------------------------------------------------
  Characteristic                                     All patients\   Abdominal infection\   Respiratory infection\   *P*-value
                                                     (n = 542)       (n = 162)              (n = 380)                
  -------------------------------------------------- --------------- ---------------------- ------------------------ -----------
  Sepsis syndromes at any time during the ICU stay                                                                   

   Severe sepsis                                     449 (82.8%)     128 (79.0%)            321 (84.5%)              0.12

   Septic shock                                      241 (44.5%)     81 (50.0%)             160 (42.1%)              0.09

  Procedures during ICU stay                                                                                         

   Mechanical ventilation                            437 (80.6%)     129 (79.6%)            308 (81.1%)              0.70

   Hemofiltration                                    69 (12.7%)      29 (17.9%)             40 (10.5%)               0.02

   Hemodialysis                                      27 (5.0%)       8 (4.9%)               19 (5.0%)                0.97

  SOFA scores                                                                                                        

   SOFA max                                          8.4 ± 4.4       8.4 ± 4.8              8.4 ± 4.3                0.90

   SOFA mean                                         5.6 ± 3.9       5.6 ± 4.0              5.6 ± 3.9                0.95

  Early organ failure^a^                                                                                             

   Renal                                             174 (32.1%)     62 (38.3%)             112 (29.5%)              0.04

   Respiratory                                       286 (52.8%)     79 (48.8%)             207 (54.5%)              0.22

   Coagulation                                       64 (11.8%)      28 (17.3%)             36 (9.5%)                0.01

   Hepatic                                           33 (6.1%)       7 (4.3%)               26 (6.8%)                0.26

   CNS                                               132 (24.4%)     16 (9.9%)              116 (30.5%)              \< 0.001

   Cardiovascular                                    249 (45.9%)     90 (55.6%)             159 (41.8%)              0.003

  Late organ failure^b^                                                                                              

   Renal                                             74 (13.7%)      16 (9.9%)              58 (15.3%)               0.09

   Respiratory                                       56 (10.3%)      17 (10.5%)             39 (10.3%)               0.93

   Coagulation                                       16 (3.0%)       7 (4.3%)               9 (2.4%)                 0.21

   Hepatic                                           16 (3.0%)       8 (4.9%)               8 (2.1%)                 0.07

   CNS                                               27 (5.0%)       8 (4.9%)               19 (5.0%)                0.97

   Cardiovascular                                    30 (5.5%)       6 (3.7%)               24 (6.3%)                0.22

  Organ failure any time                                                                                             

   Renal                                             248 (45.8%)     78 (48.1%)             170 (44.7%)              0.46

   Respiratory                                       342 (63.1%)     96 (59.3%)             246 (64.7%)              0.22

   Coagulation                                       80 (14.8%)      35 (21.6%)             45 (11.8%)               0.003

   Hepatic                                           49 (9.0%)       15 (9.3%)              34 (8.9%)                0.90

   CNS                                               159 (29.3%)     24 (14.8%)             135 (35.5%)              \< 0.001

   Cardiovascular                                    279 (51.5%)     96 (59.3%)             183 (48.2%)              0.01
  ------------------------------------------------------------------------------------------------------------------------------

CNS: Central nervous system; ^a^, occurring within 48 hours of a diagnosis of sepsis;

^b^, occurring more than 48 hours after a diagnosis of sepsis

Patients with abdominal infection also had a greater incidence of early coagulation failure (17.3% vs. 9.5%, *P*= 0.01) and early acute renal failure (38.3% vs. 29.5%, *P*= 0.04), and more needed hemofiltration than patients with respiratory infection. Patients with respiratory infection were more likely to have early neurological failure than patients with abdominal infection (30.5% vs. 9.9%, *P*\< 0.001).

The median duration of ICU stay was the same in the two groups, but the median duration of hospital stay was longer for patients with abdominal infection (27 days vs. 20 days, *P*= 0.02). ICU (29.0% vs. 28.9%) and hospital (37.5% vs. 38.1%) mortality rates were remarkably similar in the two groups of patients. In a Kaplan Meier survival analysis, 60-day survival was similar between groups (Log Rank = 0.267, *P*= 0.605; Figure [2](#F2){ref-type="fig"}). In Cox regression analysis (Table [6](#T6){ref-type="table"}), age, cancer, septic shock on admission, early coagulation failure, acute renal failure, and neurological failure were all associated with an increased risk of death, but abdominal or respiratory infection were not.

###### 

Summary of Cox proportional hazard regression analysis with hospital mortality as the dependent variable

                                   Estimated coefficient   SE     Hazard ratio (95% CI)   *P*-value
  -------------------------------- ----------------------- ------ ----------------------- -----------
  Age, per year                    0.04                    0.01   1.04 (1.03 to 1.05)     \< 0.001
  Cancer                           0.57                    0.20   1.76 (1.20 to 2.59)     0.004
  Septic shock on admission        0.42                    0.15   1.52 (1.13 to 2.04)     0.006
  Early coagulation failure        0.98                    0.18   2.68 (1.88 to 3.80)     \< 0.001
  Early acute renal failure        0.6                     0.15   1.83 (1.37 to 2.45)     \< 0.001
  Early neurological failure       0.36                    0.16   1.43 (1.04 to 1.96)     0.029
  Abdominal/respiratory variable                                                          
   Respiratory infection           reference                                              
   Abdominal infection             0.28                    0.19   1.32 (0.91 to 1.92)     0.149

CI: confidence interval; SE: standard error of the estimate

![**Kaplan-Meier survival curves representing 60-day survival in patients with respiratory and those with abdominal infection**. Log Rank = 0.267: *P*= 0.605.](cc8909-2){#F2}

Discussion
==========

Using data from a large, prospective, pan-European database, we investigated the impact on organ failure and survival of the presence on admission of infection at two of the most common sites, the lung and the abdomen. On admission, patients with abdominal infection were more likely to have septic shock, early coagulation failure and early acute renal failure, and more needed hemofiltration than patients with respiratory infection. In contrast, patients with respiratory infections were more likely to have concurrent early neurological dysfunction than patients with abdominal infection. However, the median length of ICU stay was the same in the two groups and the two groups had identical ICU and hospital mortality rates.

The present study focused on infections originating from the lungs and the abdomen, because these two sites represent the most common causes of infection in acutely ill patients \[[@B3],[@B4],[@B6],[@B11]\], and are also associated with higher workload and increased costs compared to other infections \[[@B20]\]. On admission, 49% of patients with sepsis had respiratory infections and 21% abdominal; overall in the SOAP study, 68% of patients had respiratory and 22% abdominal infections \[[@B6]\]. Similarly, in a study of 5,878 patients from Australia and New Zealand, the site of infection was pulmonary in 50% and abdominal in 19% of the episodes \[[@B11]\]. In another European study of 14,364 patients, the lung contributed to 62% of infections and intra-abdominal infections to 15% \[[@B3]\].

Although respiratory infections are more common, several studies have suggested that abdominal infections may be more severe \[[@B3],[@B10],[@B12]-[@B15]\]. The present study supports these findings, as more patients with abdominal infections than with respiratory infections had septic shock on admission. Nevertheless, mortality rates were similar in patients with abdominal and those with respiratory infections. The association between respiratory infection and a higher incidence of early neurological failure may be because respiratory infections are more common in patients with altered mental status or neurological diagnoses \[[@B21]-[@B23]\]; in our study, there was a higher proportion of neurological diagnoses in patients with respiratory infections than in those with abdominal infections. Moreover, although the assumed Glasgow coma score is supposed to be used for the SOFA score, it is possible that neurological dysfunction may have been overestimated in sedated patients. The association between abdominal infections and coagulation failure may be related to the fact that more patients with abdominal infections had septic shock, which frequently provokes coagulation abnormalities \[[@B24]\], or by the fact that most of these patients were postoperative, as surgery may be associated with altered coagulation \[[@B25],[@B26]\]. However, all these suggestions remain speculative as our study design does not allow us to determine the reasons underlying these associations.

It has been fairly consistently reported that secondary infections are more frequent among patients who are already infected when admitted to the ICU, but differences in definitions make it difficult to compare studies \[[@B3],[@B4],[@B13],[@B27],[@B28]\]. Alberti et al. \[[@B3]\] reported that 26% of patients who were infected on ICU admission developed secondary infections compared to 15% of patients not infected on admission. Malacarne et al. \[[@B4]\] reported that 23% of patients admitted with infections developed secondary infections compared to 9% of those who were admitted without infection. Agarwal et al. reported that infection on admission was an independent risk factor for developing an ICU-acquired infection \[[@B27]\]. However, the above studies focused on patients admitted with any infection without distinguishing the type. In our study, secondary infections occurred more commonly in patients admitted with abdominal than with respiratory infection, related to their longer ICU stay as shown by the multivariate analysis. These patients also had a higher incidence of skin/wound infections compared to respiratory patients, likely related to more surgical wound infections. Merlino et al. \[[@B28]\], in a retrospective study of 168 patients with serious intra-abdominal infections, reported that 66 patients (40%) developed a secondary nosocomial infection. The presence of secondary infections is associated with an increased length of stay \[[@B29]\], but the effect of secondary infections on mortality is controversial, because patients who develop secondary infections are generally sicker and more likely to die \[[@B2]-[@B7],[@B27],[@B30]\].

Interestingly, there were no differences in ICU (29%) or hospital (38%) mortality between the two groups despite the greater incidence of septic shock on admission in patients with abdominal infections. Mortality rates in studies of infection and sepsis in the ICU are quite variable. In studies in surgical ICUs, ICU mortality rates in patients with abdominal infections varied from 22% to 72% \[[@B13]-[@B15],[@B28],[@B31]-[@B33]\]. ICU mortality rates for patients with community-acquired pneumonia range from 32% to 49% \[[@B22],[@B34]-[@B36]\], and are perhaps higher in patients with hospital-acquired pneumonia \[[@B37]\]. Malacarne and colleagues found that among different sites of infection, only peritonitis diagnosed during the ICU stay was an independent prognostic factor for hospital mortality (OR 3.4, *P*= 0.0021) \[[@B4]\]. Although in our study, ICU lengths of stay were similar, the hospital length of stay was longer in patients with abdominal infection than in those with respiratory infection. We can speculate that this may be due to differences in baseline characteristics and the surgical nature of abdominal infections which can require more prolonged periods for resolution.

The advantage of our study is that it involves a large database from multiple centers with systematic collection of data. One limitation of the study is that the diagnoses of abdominal and respiratory infections were made at the discretion of the attending physician and criteria may have varied slightly from one center to another. As part of an observational study with a waiver of informed consent, we were unable to perform invasive tests to obtain more specific diagnoses and had to rely on what was routine clinical practice in the participating centers. In addition, we were unable to distinguish between hospital- and community-acquired infections. Moreover, septic shock was defined as the presence of infection plus the need for vasopressor agents, according to standard criteria at the time of the study. However, particularly in surgical patients, vasopressors may be required as a result of anesthetic agents, epidural anesthesia, blood loss, and so on, so that in the presence of infection it may be difficult to accurately distinguish the specific reason for vasopressor agents, thus confounding the diagnosis. Moreover, there were some differences in patient characteristics among the two groups of patients, but the multivariate analysis we performed adjusted for a large number of these and other variables which are known to influence outcome prediction.

Conclusions
===========

This analysis revealed that the two most common sources of infection on admission to the ICU are associated with different profiles. Patients with abdominal infection on admission are more likely to have septic shock on admission and to have early renal and coagulation failure, whereas patients with respiratory infection more commonly have early alteration in neurological function. The length of hospital stay in patients with abdominal infection is longer, likely because of the increased numbers of secondary infections in these patients. However, mortality rates were identical in the two groups of patients. These observations outline interesting differences depending on the source of sepsis, which may have important implications for our understanding of the epidemiology of sepsis and in the conduct of clinical trials.

Key messages
============

• ICU patients admitted with abdominal infections have different profiles compared to those admitted with respiratory infections.

• ICU patients admitted with abdominal infections had longer hospital lengths of stay and increased numbers of secondary infections compared to patients admitted with respiratory infections.

• However, ICU and hospital mortality rates were the same regardless of the source of sepsis.
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